Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial by Vincent Cottin, Fernando J. Martinez, R. Gisli Jenkins, John A. Belperio, Hideya Kitamura, Maria Molina-Molina, Inga Tschoepe, Carl Coeck, Dirk Lievens, Ulrich Costabel

Get full text